Related Experiment Video
Updated: Sep 3, 2025

03:37
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
872
Protocol for using Ciclops to build models trained on cross-platform transcriptome data for clinical outcome
Elysia Chou1, Hanrui Zhang1, Yuanfang Guan2
1Department of Computational Medicine and Bioinformatics, Michigan Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
STAR Protocols
|July 26, 2022
Summary
This study introduces Ciclops, a new software for building explainable clinical outcome prediction models using cross-platform data. Ciclops enhances model generalizability and aids in identifying potential biomarkers.
Area of Science:
- Computational biology
- Biostatistics
- Machine learning in healthcare
Background:
- Predicting clinical outcomes using cross-platform data presents challenges in model robustness and generalizability.
- Explainable models are crucial for understanding performance variations due to sample conditions.
Purpose of the Study:
- To present Ciclops, a freely available software for developing explainable predictive models.
- To enable robust clinical outcome predictions across diverse, cross-platform datasets.
- To integrate SHAP analysis for biomarker discovery.
Main Methods:
- Utilized Ciclops software for cross-platform training of predictive models.
- Employed SHAP (SHapley Additive exPlanations) for post-training analysis.
- Validated model performance and explainability on cross-platform clinical datasets.
Main Results:
- Ciclops successfully builds explainable models for clinical outcome prediction.
- The developed models demonstrate generalizability across different datasets.
- SHAP analysis effectively identified potential biomarkers associated with clinical outcomes.
Conclusions:
- Ciclops provides a valuable tool for creating reliable and interpretable predictive models in clinical research.
- The approach facilitates biomarker discovery and enhances the understanding of model behavior.
- This method improves the application of machine learning to cross-platform clinical data.

